JAX U19 grant (IMAGE)
Caption
Researchers led by Cathleen Lutz, Ph.D., are using an exciting new method, preclinical genomic editing, to develop safe, effective therapies for rare diseases and bring them to the clinic.
Credit
The Jackson Laboratory
Usage Restrictions
none
License
Original content